Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Tetra Bio Pharma Inc (TBP)

CBOE Canada
Currency in CAD
Disclaimer
0.03
0.00(0.00%)
Real-time Data

TBP Comments

Guy Chamberland is a liar, all the promises are missed out, no approvals ,no products ,no share value. he is making TBP a salary generating company thats it.
what happen to this?any one have an idea.
what happen to this?any one have an idea.
Quebec just invested 5 million$ , its a buy at this level.
Quebec just invested 5 million$ , its a buy at this level.
Save ur money amd stay away from this one
Let the good times roll
Ya !! good news for Tetra Bio
Yessss
Cash flows from operating activities - continuing operations (11,612,825)
Good News for ADRS-003: Based on the safety data, the medicinal ingredient and the sterile injectable drug product ARDS-003 are both safe for use in humans
Big news!!!
What is it ?
seems like just a waiting game at this point
i believe reports say they have partners to get it out to pharmacies in mid 2020... listened to their podcasts and it's an exciting wait
BOOM 2nd DIN
Back above $1 by end of Feb. EZ double on the next 60 days at this point still!
how's your dollar per share doing
was going to post this!
Health canada just approved one of their OTC drug
Buying!!!
What makes you sure, and where are you getting out?
In at .21 out at .37. Left 3k shares to see if it continues next week.
Should of held. we going above $1 in no time!! glta
good trade though! I would go buy some tbh.wt.a to have exposure for later down the line. You will thank me later
Back above $1 by May 2020. easily. Warrants supper cheap to. buy on news!
Looking good
Energy drink was a terrible idea. Competing against big companies, have regulators up the ass and the product doesn't even have cbd or thc in it, just hemp sugar. These guys need to make a new product and go back to trying to dev a inflammation drug like they originally were. Saying this as someone holding enough to know what's up.
The stock went down coz of the units offering?
This time sure, but generally the fall from $1.10 was because of the above reasons. C levels in this company need to figure it out quick.
the drink will be cross skewed into CBD and THC when the time comes. They are establishing a recognized brand prior to release. one of the few thinking ahead if you ask me. next 3 more DIN#s and a big phat Buyout from big pharma at some point. jmho
technically ,this company should grow in next 6 months. i think we touched the bottom and the next spoke will be upto $1 and + per share. if you had enough balls buy it at $0.62c than it's quite possibly you will get a good gains in next 6 months.
technically ,this company should grow in next 6 months. i think we touched the bottom and the next spoke will be upto $1 and + per share. if you had enough balls buy it at $0.62c than it's quite possibly you will get a good gains in next 6 months.
What do guys think of this company?
DIN# for first smokable cannabis product in the world on prescription, plus a pile more drugs in clinical trials, this could be a gem. I just bought a pile for my 5 year retirement plan. The Next GW Pharma...
This is a long term stock. They are in a Medical R&D mode right, not growth. They will boom, but not for some time. This stock you buy and forget about it until they spike.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.